AMLX

Amylyx Pharmaceuticals Inc

Price

$38.60

return (12m)

393.61%

p/e

-15.87

p/bv

10.09

DIVIDEND YIELD

0.00%

AMLX price

Amylyx Pharmaceuticals Inc

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AMLX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

110.07%

3 months

177.10%

1 year

393.61%

2 years

1,607.96%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AMLX

Valuation

P/E

-15.87

Sector 7.79

Industry 7.79

P/BV

10.09

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.22

Industry 2.22

EV/EBITDA

Sector -156.98

Industry -156.98

EV/EBIT

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

-32.41

Sector 2.51

Industry 2.51

P/EBIT

-32.25

Sector 0.34

Industry 0.34

P/Total Assets

9.12

Sector 1.00

Industry 1.00

P/Net Current Assets

10.45

Sector -3.84

Industry -3.84

P/Working Capital

10.26

Sector -5,077.26

Industry -5,077.26

EPS

-1.37

Sector 0.67

Industry 0.67

BVPS

2.15

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

0.00%

Sector 32.61%

Industry 32.61%

EBITDA Margin

Sector -284.80%

Industry -284.80%

EBIT Margin

Sector -4.02%

Industry -4.02%

Operating Margin

0.00%

Sector 4.45%

Industry 4.45%

Net Profit Margins

0.00%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-63.59%

Sector 2.05%

Industry 2.05%

ROA

-57.49%

Sector -0.90%

Industry -0.90%

ROIC

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

12.12

Sector 1.44

Industry 1.44

Net Debt / EBITDA

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

Sector -31.03

Industry -31.03

Net Debt / Equity

Sector -0.72

Industry -0.72

Gross Debt / Equity

Sector 0.21

Industry 0.21

Equity/Assets

0.90

Sector 0.43

Industry 0.43

Liabilities/Assets

0.10

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

11.58%

Sector -

Industry -

Fundamentals AMLX

DRAG THE FRAME TO SEE MORE DATA

AMLX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals Inc

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Amylyx Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $2.41 billion, with shareholders equity totaling $239.17 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Amylyx Pharmaceuticals Inc reported $- in revenue, generating net income of $-152.09 million.

Key financial metrics include a P/E ratio of -15.87, a price-to-book (P/B) ratio of 10.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AMLX.

Market cap

$2.41 billion

Net worth

$239.17 million

$239,167,000.00

Assets

$264.56 million

$264,564,000.00

Total Shares Outstanding

111.20 million

111,196,000

Average Daily Trading Volume

$1.36 million

$1,362,196.00

Sector

Others

Industry

Others

AMLX

AMLX revenue and profits

Financial Results AMLX

DRAG THE FRAME TO SEE MORE DATA

AMLX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96